Free Trial

Siga Technologies (SIGA) Competitors

Siga Technologies logo
$8.47 -0.01 (-0.12%)
Closing price 10/21/2025 04:00 PM Eastern
Extended Trading
$8.44 -0.03 (-0.40%)
As of 05:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SIGA vs. MESO, IBRX, ADPT, RXRX, IDYA, DNLI, BHC, TVTX, ETNB, and SRPT

Should you be buying Siga Technologies stock or one of its competitors? The main competitors of Siga Technologies include Mesoblast (MESO), ImmunityBio (IBRX), Adaptive Biotechnologies (ADPT), Recursion Pharmaceuticals (RXRX), IDEAYA Biosciences (IDYA), Denali Therapeutics (DNLI), Bausch Health Cos (BHC), Travere Therapeutics (TVTX), 89BIO (ETNB), and Sarepta Therapeutics (SRPT). These companies are all part of the "pharmaceutical products" industry.

Siga Technologies vs. Its Competitors

Siga Technologies (NASDAQ:SIGA) and Mesoblast (NASDAQ:MESO) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, dividends and risk.

Siga Technologies has a net margin of 45.73% compared to Mesoblast's net margin of 0.00%. Siga Technologies' return on equity of 40.52% beat Mesoblast's return on equity.

Company Net Margins Return on Equity Return on Assets
Siga Technologies45.73% 40.52% 35.62%
Mesoblast N/A N/A N/A

Siga Technologies has higher revenue and earnings than Mesoblast.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siga Technologies$138.72M4.37$59.21M$1.137.50
Mesoblast$17.20M136.72-$102.14MN/AN/A

In the previous week, Mesoblast had 5 more articles in the media than Siga Technologies. MarketBeat recorded 7 mentions for Mesoblast and 2 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 1.00 beat Mesoblast's score of 0.39 indicating that Siga Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Siga Technologies
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mesoblast
1 Very Positive mention(s)
3 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Mesoblast has a consensus price target of $24.00, indicating a potential upside of 30.65%. Given Mesoblast's stronger consensus rating and higher probable upside, analysts plainly believe Mesoblast is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Siga Technologies
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Mesoblast
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.80

55.4% of Siga Technologies shares are owned by institutional investors. Comparatively, 1.4% of Mesoblast shares are owned by institutional investors. 2.0% of Siga Technologies shares are owned by company insiders. Comparatively, 18.8% of Mesoblast shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Siga Technologies has a beta of 0.96, indicating that its share price is 4% less volatile than the S&P 500. Comparatively, Mesoblast has a beta of 2.3, indicating that its share price is 130% more volatile than the S&P 500.

Summary

Mesoblast beats Siga Technologies on 8 of the 15 factors compared between the two stocks.

Get Siga Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SIGA vs. The Competition

MetricSiga TechnologiesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$607.22M$3.01B$6.21B$10.68B
Dividend YieldN/A57.76%5.72%4.88%
P/E Ratio7.5023.5929.1427.23
Price / Sales4.37780.79587.91132.66
Price / Cash10.13171.3937.5161.65
Price / Book2.805.4112.526.59
Net Income$59.21M$33.06M$3.32B$276.14M
7 Day Performance0.59%-0.68%0.77%-0.72%
1 Month Performance-9.61%8.13%7.29%2.47%
1 Year Performance27.37%-2.15%64.58%33.90%

Siga Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SIGA
Siga Technologies
2.0213 of 5 stars
$8.47
-0.1%
N/A+23.1%$607.22M$138.72M7.5040
MESO
Mesoblast
2.0166 of 5 stars
$18.14
-1.0%
$24.00
+32.3%
+90.4%$2.34B$17.20M0.0080News Coverage
Gap Up
IBRX
ImmunityBio
2.8087 of 5 stars
$2.48
+5.1%
$10.75
+333.5%
-31.3%$2.32B$14.74M-5.17590
ADPT
Adaptive Biotechnologies
2.9706 of 5 stars
$15.50
+2.2%
$13.56
-12.5%
+281.3%$2.31B$178.96M-18.90790
RXRX
Recursion Pharmaceuticals
1.9301 of 5 stars
$5.53
+3.9%
$7.25
+31.1%
-9.6%$2.31B$58.84M-3.11400
IDYA
IDEAYA Biosciences
4.3241 of 5 stars
$26.77
+2.0%
$43.36
+62.0%
-5.4%$2.30B$7M-7.0680Trending News
Analyst Forecast
DNLI
Denali Therapeutics
4.2162 of 5 stars
$14.98
-2.5%
$33.50
+123.6%
-35.7%$2.25B$330.53M-5.35430
BHC
Bausch Health Cos
4.6869 of 5 stars
$6.15
+1.6%
$9.00
+46.5%
-24.9%$2.24B$9.63B23.6420,700Upcoming Earnings
TVTX
Travere Therapeutics
2.973 of 5 stars
$26.20
+4.1%
$35.21
+34.4%
+53.6%$2.24B$233.18M-12.84460
ETNB
89BIO
3.1974 of 5 stars
$14.80
flat
$25.81
+74.4%
+82.0%$2.19BN/A-4.1040Short Interest ↓
SRPT
Sarepta Therapeutics
4.6552 of 5 stars
$21.96
-0.7%
$34.42
+56.7%
-81.7%$2.16B$1.90B-25.241,372Positive News

Related Companies and Tools


This page (NASDAQ:SIGA) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners